TuisH6D0 • ETR
add
Haleon PLC
Vorige sluiting
€4,03
Dagwisseling
€4,00 - €4,03
Jaarwisseling
€3,75 - €5,12
Markkapitalisasie
41,28 mjd USD
Gemiddelde volume
9,18 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
LON
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (GBP) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 2,74 mjd | -1,26% |
Bedryfskoste | 1,16 mjd | 0,43% |
Netto inkomste | 403,00 m | 33,00% |
Netto winsgrens | 14,71 | 34,71% |
Wins per aandeel | — | — |
EBITDA | 667,00 m | -3,19% |
Effektiewe belastingkoers | 24,37% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (GBP) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 676,00 m | 27,31% |
Totale bates | 31,83 mjd | -4,70% |
Totale aanspreeklikheid | 15,83 mjd | -5,15% |
Totale ekwiteit | 16,00 mjd | — |
Uitstaande aandele | 9,03 mjd | — |
Prys om te bespreek | 2,28 | — |
Opbrengs op bates | 4,78% | — |
Opbrengs op kapitaal | 6,20% | — |
Kontantvloei
Netto kontantverandering
| (GBP) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 403,00 m | 33,00% |
Kontant van bedrywe | 513,50 m | — |
Kontant van beleggings | -38,00 m | — |
Kontant van finansiering | -1,26 mjd | — |
Netto kontantverandering | -790,50 m | — |
Beskikbare kontantvloei | 369,81 m | — |
Meer oor
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
Gestig
18 Jul. 2022
Webwerf
Werknemers
24 561
